業(yè)執(zhí)照.jpg)
毛蕊異黃酮
分析標(biāo)準(zhǔn)品,HPLC≥98%
Calycosin
CAS號(hào)：20575-57-9
分子式： C16H12O5
分子量：284.26
MDL：MFCD00210598
別名：毛異黃酮; ;3',7-Dihydroxy-4'-methoxy-isoflavone; Calycosin; 7,3'-dihydroxy-4'-methoxyisoflavone; 3',7-dihydroxy-4'-methoxyisoflavone; 7-hydroxy-3-(3-hydroxy-4-methoxyphenyl)chromen-4-one
貨號(hào) | 規(guī)格/參數(shù)/品牌 | 價(jià)格 | 貨期 |
YJ-B20846-20mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥1020.00 | 現(xiàn)貨 |
YJ-B20846-100mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥2680.00 | 現(xiàn)貨 |
產(chǎn)品介紹
熔點(diǎn)：245-247℃
沸點(diǎn)：536.8℃ at 760mmHg
外觀：白色針晶 (甲醇)
溶解性：DMSO : ≥ 28 mg/mL (98.50 mM)
儲(chǔ)存條件：2-8℃
注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)*威性，僅供客戶(hù)參考交流研究之用。
參考文獻(xiàn)(87篇)
87. [IF=5.1] Bin Lu et al."Selenium nanoparticles combined with Calycosin treated sepsis through synergistic anti-inflammatory and antioxidant effects."Nanoscale.2025 Jun;:
86. [IF=5.4] Jin-Jin Zhang et al."Calycosin limits hepatic fibrogenesis via KLF15 dependent repression of P2X7R in thioacetamide-induced hepatic fibrosis."JOURNAL OF ETHNOPHARMACOLOGY.2025 Jun;:120194
85. [IF=1.7] Qi-Rui He et al."Rapid and Systematic Characterization of Chemical Constituents in Astragali radix–Curcumae rhizoma Herb Pair Using an UPLC-QTOF-MS–Based Strategy."BIOMEDICAL CHROMATOGRAPHY.2025 May;39(7):e70097
84. [IF=6.7] Mingzhu Qi et al."Qingxin Jieyu Granule alleviates myocardial infarction through inhibiting neutrophil extracellular traps via activating ANXA1/FPR2 axis."PHYTOMEDICINE.2024 Dec;135:156147
83. [IF=4.2] Yuxin Chen et al."Demyelination in cuprizone mice is ameliorated by Calycosin mediated through astrocyte Nrf2 signaling pathway."EUROPEAN JOURNAL OF PHARMACOLOGY.2024 Nov;:177090
82. [IF=8.5] Shengnan Wang et al."Postharvest changes in the phenolic and free volatile compound contents in Shine Muscat grapes at room temperature."FOOD CHEMISTRY.2025 Feb;465:141958
81. [IF=5.6] Siyi Ma et al."Integration of feature-based molecular networking and high-definition data-dependent acquisition for the comprehensive multicomponent characterization of Honghua Xiaoyao Tablet."TALANTA.2025 Apr;285:127298
80. [IF=6.5] Wang Linjie et al."PHENYLALANINE AMMONIA-LYASE 2 regulates secondary metabolism and confers manganese tolerance in Stylosanthes guianensis."PLANT PHYSIOLOGY.2025 Jan;:
79. [IF=4.9] Yang Zhang et al."Characterization and identification of chemical components in Si-Ni-San based on UPLC-Q-Orbitrap-MS, HS-SPME-GC–MS, and HS-GC-IMS techniques."MICROCHEMICAL JOURNAL.2025 Feb;209:112718
78. [IF=4.8] Sheng Hu et al."Novel Monomers Recipe Derived from Shengji-Huayu Formula Targeting PI3K/Akt Signaling Pathway for Diabetic Wound Healing Based on Accurate Network Pharmacology."JOURNAL OF ETHNOPHARMACOLOGY.2025 Feb;:119509
77. [IF=4.2] Hua-jing Yuan et al."Calycosin treats acute myocardial infarction via NLRP3 inflammasome: Bioinformatics, network pharmacology and experimental validation."EUROPEAN JOURNAL OF PHARMACOLOGY.2025 Apr;:177621
76. [IF=4.8] Lin-Han Xiang et al."Studying the effects of Saposhnikoviae Radix on the pharmacokinetic profiles of 10 bioactive compounds originating from Astragali Radix in rat plasma by UHPLC-QTRAP-MS/MS."JOURNAL OF ETHNOPHARMACOLOGY.2024 Sep;:118813
75. [IF=2.5] Liu Yue et al."Chemical detection and analysis of Astragalus-Cassia twig drug pair using UHPLC-Q-TOF-MS and HPLC-UV methods."FITOTERAPIA.2024 Sep;177:106129
74. [IF=1.3] Hong-Ping Wang et al."Screening of potential α-glucosidase inhibitors from astragalus membranaceus by affinity ultrafiltration screening coupled with UPLC-ESI-Orbitrap-MS method."JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH.
73. [IF=6.7] Ruiqian Sun et al."Astragali Radix-Curcumae Rhizoma herb pair reduces the stemness of colorectal cancer cells through HIF-2α/β-catenin pathway."PHYTOMEDICINE.2024 Sep;132:155824
72. [IF=2.6] Fan Yang et al."Preliminary Exploration of Potential Active Ingredients and Molecular Mechanisms of Yanggan Yishui Granules for Treating Hypertensive Nephropathy Using UPLC-Q-TOF/MS Coupled with Network Pharmacology and Molecular Docking Strategy."Journal
71. [IF=2.9] Tian Chunyan et al."Blocking group 2 innate lymphoid cell activation and macrophage M2 polarization: potential therapeutic mechanisms in ovalbumin-induced allergic asthma by calycosin."BMC Pharmacology & Toxicology".2024 Dec;25(1):1-12
70. [IF=5.4] Yang Wang et al."Buyang huanwu decoction promotes remyelination via miR-760-3p/GPR17 axis after intracerebral hemorrhage."JOURNAL OF ETHNOPHARMACOLOGY".2024 Jun;328:118126
69. [IF=1.1] Xudong Luo et al."Development and validation of a simple ultra-high-performance-tandem mass spectrometry method for the simultaneous determination of five bioactive components in rat plasma of Hedysari Radix."Separation Science Plus".2024 Feb;:2300219
68. [IF=3.3] Yi-feng Ma et al."Optimization of the Zhou Tian Formula extraction technology based on AHP-CRITIC method and analysis of transfer efficiency of key components based on HPLC fingerprinting."PHYTOCHEMICAL ANALYSIS".2024 Feb;:
67. [IF=4.4] Pang Tao et al."Evaluating the Compatibility Mechanism of Shengxian Decoction Based on an Excretion Study of 18 Bioactive Constituents in Rat Biosamples."World Journal of Traditional Chinese Medicine".2024 Feb;10(1):40
66. [IF=5.4] Xin Ma et al."Calycosin enhances treg differentiation for alleviating skin inflammation in atopic dermatitis."JOURNAL OF ETHNOPHARMACOLOGY".2024 Feb;:117883
65. [IF=6.4] Lei Ma et al."Transcriptomics and metabolomics revealed the synthesis and potential role of flavonoids in pea roots under continuous cropping obstacles."PHYSIOLOGIA PLANTARUM".2024 Feb;176(1):e14185
64. [IF=5.4] Hui Ren et al."Integrated serum metabolomics and network pharmacology analysis on the bioactive metabolites and mechanism exploration of Bufei huoxue capsule on chronic obstructive pulmonary disease rats."JOURNAL OF ETHNOPHARMACOLOGY.2024 Apr;324:117816
63. [IF=5.4] Wenjuan Ma et al."Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation."JOURNAL OF ETHNOPHARMACOLOGY.2024 Apr;323:117752
62. [IF=5.4] Yingqiu Shi et al."Effective constituents and protective effect of Mudan granules against Schwann cell injury."JOURNAL OF ETHNOPHARMACOLOGY.2024 Apr;323:117692
61. [IF=3.4] Jiaxin Yin et al."Comprehensive multicomponent characterization and quality assessment of Xiaoyao Wan by UPLC-Q-Orbitrap-MS, HS-SPME-GC-MS and HS-GC-IMS."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.2024 Feb;239:115910
60. [IF=5.9] Zekun Zhou et al."Molecular Mechanism of Calycosin Inhibited Vascular Calcification."Nutrients.2024 Jan;16(1):99
59. [IF=5.4] Menghan Cheng et al."A novel strategy of integrating network pharmacology and transcriptome reveals antiapoptotic mechanisms of Buyang Huanwu Decoction in treating intracerebral hemorrhage."JOURNAL OF ETHNOPHARMACOLOGY.10.1016/j.jep.2023.117123
58. [IF=3.8] Dongli Li et al."Danggui-Buxue decoction alleviated vascular senescence in mice exposed to chronic intermittent hypoxia through activating the Nrf2/HO-1 pathway."PHARMACEUTICAL BIOLOGY.2023;61(1):1041-1053
57. [IF=1.7] Zhouyi Zhang et al."Revealing the differences in phenolics in different parts of Taraxacum mongolicum using UPLC-MS/MS."Phytochemistry Letters.2023 Aug;56:13
56. [IF=3.1] Yanmin Wang et al."Study on the dynamic metabolic characteristic of main active ingredients in Danggui Buxue Decoction by liquid chromatography-tandem mass spectrometry based on in situ sequential metabolism strategy."JOURNAL OF SEPARATION SCIENCE.2023 Ju
55. [IF=4.1] Jingtong Xia et al."Non-destructive distinction of single seed for Medicago sativa and Melilotus officinalis by capillary electrophoresis with laser-induced fluorescence detection."JOURNAL OF CHROMATOGRAPHY A.2023 Jun;:464116
54. [IF=3.614] Shu-Yun Yang et al."An integrated approach of HPLC-MS-based chemical profiling, network pharmacology, and molecular docking to reveal the potential mechanisms of Qishen Gubiao Granules for treating COVID-19."JOURNAL OF SEPARATION SCIENCE.2023 Mar;:2200953
53. [IF=6.449] Yanmei Li et al."Regional variations and plant compartments shape the community structures of the endophytic microbiome and secondary metabolites of Astragalus mongholicus."INDUSTRIAL CROPS AND PRODUCTS.2023 Feb;192:116037
52. [IF=1.698] Jinyan Wu et al."Chemical Identification and Antioxidant Screening of Bufei Yishen Formula using an Offline DPPH Ultrahigh-Performance Liquid Chromatography Q-Extractive Orbitrap MS/MS."International Journal of Analytical Chemistry.2022 Oct 15;2022:142380
51. [IF=2.605] Wang Yaxin et al."Overexpression of estrogen receptor β inhibits cellular functions of human hepatic stellate cells and promotes the anti-fibrosis effect of calycosin via inhibiting STAT3 phosphorylation."BMC Pharmacology & Toxicology.2022 Dec;23(1):1-13
50. [IF=2.65] Jing Zhou et al."Buyang Huanwu Decoction: A Traditional Chinese Medicine, Promotes Lactate-Induced Angiogenesis in Experimental Intracerebral Hemorrhage."Evidence-based Complementary and Alternative Medicine.2022 Oct 30;2022:4063315
49. [IF=5.988] Jun Li et al."Screening of anti-heart failure active compounds from fangjihuangqi decoction in verapamil-induced zebrafish model by anti-heart failure index approach.."Frontiers in Pharmacology.2022 Oct;13:999950-999950
48. [IF=4.036] Chi Ma et al."Combining multiple acquisition modes and computational data annotation for structural characterization in traditional Chinese medicine: Miao Nationality medicine Qijiao Shengbai Capsule as a case study."RSC Advances.2022 Sep;12(43):27781-277
47. [IF=5.168] Pan Wang et al."Discovery and characterization of novel ATP citrate lyase inhibitors from natural products by a luminescence-based assay."CHEMICO-BIOLOGICAL INTERACTIONS.2022 Nov;367:110199
46. [IF=6.208] Pan Wang et al."Discovery of Flavonoids as Novel Inhibitors of ATP Citrate Lyase: Structure–Activity Relationship and Inhibition Profiles."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2022 Jan;23(18):10747
45. [IF=9.231] Tong Zhao et al."Identification of characteristic markers for monofloral honey of Astragalus membranaceus var. mongholicus Hsiao: A combined untargeted and targeted MS-based study."FOOD CHEMISTRY.2022 Sep;:134312
44. [IF=5.195] Yayun Wu et al."Integrating pharmacokinetics and network pharmacology to identify and validate targets of Guben Xiaozhen prescription for the treatment of chronic urticaria."JOURNAL OF ETHNOPHARMACOLOGY.2022 Nov;298:115628
43. [IF=5.195] Xiaoqing Shi et al."Calycosin mitigates chondrocyte inflammation and apoptosis by inhibiting the PI3K/AKT and NF-κB pathways."JOURNAL OF ETHNOPHARMACOLOGY.2022 Oct;297:115536
42. [IF=6.698] Yu Gu et al."A multiomics and network pharmacological study reveals the neuroprotective efficacy of Fu-Fang-Dan-Zhi tablets against glutamate-induced oxidative cell death."COMPUTERS IN BIOLOGY AND MEDICINE.2022 Jul;:105873
41. [IF=6.576] Junkun Pan et al."Inhibition of Dipeptidyl Peptidase-4 by Flavonoids: Structure–Activity Relationship, Kinetics and Interaction Mechanism."Frontiers in Nutrition. 2022; 9: 892426
40. [IF=7.514] Jie Meng et al."Conduction of a chemical structure-guided metabolic phenotype analysis method targeting phenylpropane pathway via LC-MS: Ginkgo biloba and soybean as examples."FOOD CHEMISTRY. 2022 Oct;390:133155
39. [IF=5.34] Lei Jin et al."Simultaneous optimization of the extraction process of Yangyin Yiqi Huoxue prescription with natural deep eutectic solvents for optimal extraction yield and antioxidant activity: A comparative study of two models."PHYTOMEDICINE. 2022 Jul;102
38. [IF=3.645] Jingbin Chen et al.Screening for potential quality markers of Callerya nitida var. hirsutissima. Z.Wei based on components profile, pharmacokinetics, and anti-inflammatory study.Journal Of Separation Science.2021 Nov 02
37. [IF=3] Qu Lala et al."Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay."N-S Arch Pharmacol. 2020 Jun;393(6):937-950
36. [IF=4.225] Zhang Wei et al."Five Active Components Compatibility of Astragali Radix and Angelicae Sinensis Radix Protect Hematopoietic Function Against Cyclophosphamide-Induced Injury in Mice and t-BHP–Induced Injury in HSCs."Front Pharmacol. 2019 Aug;0:936
35. [IF=4.769] Zhenzhong Yang et al."Deciphering bioactive compounds of complex natural products by tandem mass spectral molecular networking combined with an aggregation-induced emission based probe."J Pharm Anal. 2020 Nov;:
34. [IF=4.879] Yang Liu et al."UV-B Radiation Largely Promoted the Transformation of Primary Metabolites to Phenols in Astragalus mongholicus Seedlings."Biomolecules. 2020 Apr;10(4):504
33. [IF=5.34] Tao-Fang Cheng et al."Compound Dan Zhi tablet attenuates experimental ischemic stroke via inhibiting platelet activation and thrombus formation."Phytomedicine. 2020 Dec;79:153330
32. [IF=5.455] Zhang Xian et al."Neurobehavioral alternations of the female offspring born to polycystic ovary syndrome model rats administered by Chinese herbal medicine."Chin Med-Uk. 2021 Dec;16(1):1-19
31. [IF=5.81] Gu Junfei et al."Standardized Astragalus Mongholicus Bunge-Curcuma Aromatica Salisb. Extract Efficiently Suppresses Colon Cancer Progression Through Gut Microbiota Modification in CT26-Bearing Mice."Front Pharmacol. 2021 Aug;0:2278
30. [IF=6.529] Xiaoguang Lu et al."Calycosin attenuates doxorubicin-induced cardiotoxicity via autophagy regulation in zebrafish models."Biomed Pharmacother. 2021 May;137:111375
29. [IF=2.233] Fei Li et al."Effects of Astragalus Combined with Angelica on Bone Marrow Hematopoiesis Suppression Induced by Cyclophosphamide in Mice."Biol Pharm Bull. 2017 May;40(5):598-609
28. [IF=2.894] Lulu Lu et al."Calycosin promotes lifespan in Caenorhabditis elegans through insulin signaling pathway via daf-16, age-1 and daf-2."J Biosci Bioeng. 2017 Jul;124:1
27. [IF=3.205] Min He et al."Simultaneous determination of multiple bioactive components of Bu-zhong-yi-qi-tang in rat tissues by LC–MS/MS: Application to a tissue distribution study."J Chromatogr B. 2017 Feb;1044-1045:177
26. [IF=3.361] Taofang Cheng et al."Hybrid multidimensional data acquisition and data processing strategy for comprehensive characterization of known, unknown and isomeric compounds from the compound Dan Zhi Tablet by UPLC-TWIMS-QTOFMS."Rsc Adv. 2019 Mar;9(16):8714-8727
25. [IF=3.935] Nan Mi et al."Metabolite profiling of traditional Chinese medicine formula Dan Zhi Tablet: An integrated strategy based on UPLC-QTOF/MS combined with multivariate statistical analysis."J Pharmaceut Biomed. 2019 Feb;164:70
24. [IF=4.759] Yuping Zhang et al."On-line surface plasmon resonance-high performance liquid chromatography–tandem mass spectrometry for analysis of human serum albumin binders from Radix Astragali."J Chromatogr A. 2013 Jun;1293:92
23. Yang, Zhenzhong, et al. "Deciphering bioactive compounds of complex natural products by tandem mass spectral molecular networking combined with an aggregation-induced emission based probe." Journal of Pharmaceutical Analysis (2020).https:##doi.org/10.1016/
22. Xing-Yan, L. I. U., et al. "Identification of active compound combination contributing to anti-inflammatory activity of Xiao-Cheng-Qi Decoction via human intestinal bacterial metabolism." Chinese journal of natural medicines 16.7 (2018): 513-524.https:##do
21. Li, Fei, et al. "Effects of Astragalus combined with Angelica on bone marrow hematopoiesis suppression induced by cyclophosphamide in mice." Biological and Pharmaceutical Bulletin 40.5 (2017): 598-609.https:##doi.org/10.1248/bpb.b16-00802
20. 馮紫薇. 子洲黃芪飲片質(zhì)量等級(jí)標(biāo)準(zhǔn)研究[D].北京中醫(yī)藥大學(xué),2020.
19. 張麗,卞曉坤,趙秋龍,錢(qián)大瑋,郭盛,嚴(yán)輝,歐陽(yáng)臻,趙建軍,段金廒.基于多元成分的黃芪藥材產(chǎn)地現(xiàn)代干燥加工方法[J].中國(guó)現(xiàn)代中藥,2020,22(10):1684-1688.
18. 孫秀蕊,魏桂杰,王宏雅,趙雯雯,張哲,張婷,魏鋒,張玉杰.基于外觀性狀和內(nèi)在成分的黃芪藥材質(zhì)量等級(jí)評(píng)價(jià)[J].中國(guó)中藥雜志,2021,46(04):966-971.
17. 王維,張路陽(yáng),趙子龍,張東勇,包義君.毛蕊異黃酮抑制膠質(zhì)瘤細(xì)胞增殖的機(jī)制研究[J].沈陽(yáng)藥科大學(xué)學(xué)報(bào),2020,37(08):725-729+755.
16. 毛文點(diǎn),庹玲玲,齊文續(xù),蘇睿智,鄧常清,鄒龍.黃芪-當(dāng)歸不同配伍對(duì)其6種主要有效成分溶出的影響[J].湖南中醫(yī)藥大學(xué)學(xué)報(bào),2021,41(03):350-354.
15. 敏,王猛猛,吳雨,陳文文,王之通,張磊陽(yáng),蔣健.補(bǔ)中益氣湯6個(gè)成分在大鼠體內(nèi)的藥代動(dòng)力學(xué)研究[J].遼寧中醫(yī)雜志,2020,47(11):159-163.
14. 張倩,楊懷瑾,周悅,余亦婷,莊欣雅,毛春芹,謝輝,李林,陸兔林,嚴(yán)國(guó)俊.基于傳統(tǒng)煎藥工藝的黃芪藥材HPLC指紋圖譜及化學(xué)計(jì)量學(xué)質(zhì)量評(píng)價(jià)研究[J].中草藥,2021,52(04):1128-1134.
13. 姚靜, 施鈞瀚, 桂新景,等. 基于HPLC指紋圖譜評(píng)價(jià)的當(dāng)歸補(bǔ)血湯傳統(tǒng)湯劑與配方顆粒湯劑的成分差異分析[J]. 中草藥, 2019(11).
12. 尚興樸,歐陽(yáng)羅丹,肖蘇萍,王繼永,高永堅(jiān),袁春平,劉暢.黃芪飲片質(zhì)量評(píng)價(jià)和分級(jí)標(biāo)準(zhǔn)探討[J].中國(guó)現(xiàn)代中藥,2020,22(05):772-779.
11. 李欣, 卓冰雨, 祁曉娟,等. 黃芪異黃酮含量與氣候因子的灰色關(guān)聯(lián)度和通徑分析[J]. 中國(guó)中藥雜志 2020年45卷14期, 3407-3413頁(yè), MEDLINE ISTIC PKU CSCD CA BP, 2020.
10. 侯美如, 尹珺伊, 王巖,等. 黃芪發(fā)酵前后黃酮含量及指紋圖譜比較研究[J]. 中國(guó)獸藥雜志, 2018, v.52(05):52-58.
9. 王維, 張路陽(yáng), 趙子龍,等. 毛蕊異黃酮抑制膠質(zhì)瘤細(xì)胞增殖的機(jī)制研究[J]. 沈陽(yáng)藥科大學(xué)學(xué)報(bào), 2020(8):725-729.
8. 周樂(lè), 趙曉莉, 狄留慶,等. 大鼠在體單向腸灌流模型研究毛蕊異黃酮的吸收特征[J]. 南京中醫(yī)藥大學(xué)學(xué)報(bào), 2014, 30(2):160-163.
7. 石巖, 熊婧, 魏鋒,等. 基于機(jī)器學(xué)習(xí)及外部"探針"策略的HPLC保留時(shí)間預(yù)測(cè)的研究[J]. 藥物分析雜志, 2019, 39(04):160-165.
6. 何昊 許暢 王興中 蘇力 張家旭. 四種不同方法提取黃芪中黃芪甲苷的對(duì)比研究[J]. 化工科技(3期):25-28.
5. 劉杰 何鋼 劉賢桂 等. 人工栽培雞血藤中五種黃酮類(lèi)物質(zhì)含量測(cè)定[J]. 分子植物育種 2017 015(009):3832-3837.
4. 唐蓉 張依人 陳葉童 蔣龍波 鄧常清 鄒龍.不同劑量配伍對(duì)黃芪-當(dāng)歸中5種化學(xué)成分的影響[J].中國(guó)實(shí)驗(yàn)方劑學(xué)雜志 2016 22(23):1-5.
3. 劉雪 石曉倩 吳晏杰 等. UPLC法同時(shí)測(cè)定新安名方腦絡(luò)欣通中5個(gè)活性成分的含量[J]. 貴陽(yáng)中醫(yī)學(xué)院學(xué)報(bào) 2020年42卷4期 26-31頁(yè) ISTIC 2020.
2. 支旭然 劉洪濤 吳茵 等. UPLC-MS/MS法同時(shí)測(cè)定腎康注射液中7個(gè)有效成分[J]. 藥物分析雜志 2017 037(001):37-42.
1. 黃翠云 陳靜 張鳳 等. HPLC-MS/MS測(cè)定酒石酸溴莫尼定滴眼液的含量[J]. 海峽藥學(xué) 2020 v.32;No.241(02):56-58.
從2011年開(kāi)始我們致力于在生命科學(xué)領(lǐng)域、生物醫(yī)學(xué)實(shí)驗(yàn)技術(shù)及論文潤(rùn)色服務(wù)，協(xié)助客戶(hù)各類(lèi)實(shí)驗(yàn)服務(wù)及論文潤(rùn)色十余年，是客戶(hù)您值得信賴(lài)的科研合作伙伴!
如果您受時(shí)間、試驗(yàn)條件等限制而無(wú)法完成您的課題研究，歡迎您與我們聯(lián)系。
實(shí)驗(yàn)技術(shù)服務(wù)：
毛蕊異黃酮
分析標(biāo)準(zhǔn)品
